1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Bergas A, Albasanz-Puig A, Fernández-Cruz A, Machado M, Novo A, van Duin D, Garcia-Vidal C, Hakki M, Ruiz-Camps I, Del Pozo JL, Oltolini C, DeVoe C, Drgona L, Gasch O, Mikulska M, Martín-Dávila P, Peghin M, Vázquez L, Laporte-Amargós J, Durà-Miralles X, Pallarès N, González-Barca E, Álvarez-Uría A, Puerta-Alcalde P, Aguilar-Company J, Carmona-Torre F, Clerici TD, Doernberg SB, Petrikova L, Capilla S, Magnasco L, Fortún J, Castaldo N, Carratalà J, Gudiol C.

    Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).

    Microbiology spectrum . : .

    [doi:10.1128/spectrum.02292-21]

  • Esteban-Cartelle B, Vicente-Oliveros N, Menéndez-Conde CP, Serrano DR, Martín-Dávila P, Fortún-Abete J, León-Gil LA, Álvarez-Díaz A.

    Antibiotic stability in portable elastomeric infusion devices: A systematic review.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists . : .

    [doi:10.1093/ajhp/zxac122]

  • Poveda E, Fitzgerald W, Reglero C, Pérez-González A, Mariño A, Álvarez H, Valcarce N, Llibre JM, Guillén SM, Fernández MAM, Ruiz-Mateos E, Margolis L, Lederman MM, Freeman ML.

    IL-18 and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1.

    JOURNAL OF INFECTIOUS DISEASES . : .

    [doi:10.1093/infdis/jiad042]

  • Pérez-Nadales E, Fernández-Ruiz M, Natera AM, Gutiérrez-Gutiérrez B, Mularoni A, Russelli G, Pierrotti LC, Freire MP, Falcone M, Tiseo G, Tumbarello M, Raffaelli F, Abdala E, Bodro M, Gervasi E, Fariñas MC, Seminari EM, Castón JJ, Marín-Sanz JA, Gálvez-Soto V, Rana MM, Loeches B, Martín-Dávila P, Pascual Á, Rodríguez-Baño J, Aguado JM, Martínez-Martínez L, Torre-Cisneros J.

    Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae.

    AMERICAN JOURNAL OF TRANSPLANTATION . : .

    [doi:10.1016/j.ajt.2023.03.011]

  • López-Olivencia M, de Pablo R, de Dios NP, García-Plaza S, Sáez-Noguero S, de la Fuente JS, Fortún J, Cuesta MCS.

    The adverse impact of cytomegalovirus infection on intensive care units outcomes in critically ill COVID-19 patients: a single-center prospective observational study.

    Infection . : .

    [doi:10.1007/s15010-025-02499-8]

  • Sastre-Escolà E, Ntziora F, Chiurlo M, Martín-Dávila P, Mikulska M, Albasanz-Puig A, Machado M, Gutiérrez-Villanueva A, Márquez-Gómez I, Gasch-Blasi O, Sipsas NV, Oltolini C, Fortún J, Ruiz-Camps I, Fernández-Cruz A, Peña M, Laporte-Amargos J, Bergas A, Badia-Tejero AM, Carratalà J, Gudiol C.

    Ceftazidime/avibactam for the treatment of bloodstream infection due to carbapenemase-producing Enterobacterales in onco-haematologic neutropenic patients (the TARZAN study).

    The Journal of antimicrobial chemotherapy . : .

    [doi:10.1093/jac/dkaf120]

  • Casado JL, Vizcarra P, Martín-Hondarza A, Moreno A, Pérez-Elías MJ, Fernández-Chica C, Martín-Colmenarejo S, Vallejo A.

    Humoral and cellular immune responses in people living with HIV following successive COVID-19 vaccine booster doses.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . : .

    [doi:10.1016/j.cmi.2025.06.007]

  • García-Ruiz de Morales AG, Suárez Robles M, Pérez-Elías MJ, Negredo E, Alcamí J, Gómez Rodríguez CE, González-Ruano P, de Zárraga Fernández MA, Dueñas Gutiérrez C, Moreno Guillén S, Martínez-Sanz J.

    Metabolic Complications After Initiating BIC/FTC/TAF Versus DTG + 3TC in ART-naive Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study.

    CLINICAL INFECTIOUS DISEASES . : .

    [doi:10.1093/cid/ciae645]

  • Izquierdo R, Vallejo A, Suárez-García I, Martín-Hondarza A, Gutierrez F, Perez-Molina JA, García DV, Macías J, Rivero A, Olalla J, Montero-Alonso M, Asensi V, Moreno S, Jarrín I, Rava M.

    Markers of inflammation and immune dysfunction and non-AIDS cancer risk in adults with HIV.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . : .

    [doi:10.1097/QAI.0000000000003667]

  • Ollero MJF, Ryan P, Dolengevich-Segal H, Cano-Smith J, Ramos-Ruperto L, Cabello A, Sanchez-Conde M, Cabello N, Sanz J, García-Fraile LJ, Perez-Latorre L, Bisbal O, De La Fuente S, Losa JE, González-Baeza A.

    Drug Addiction in Gay and Bisexual Men Living with HIV Engaged in Sexualized Drug Use: Recent Drug Use, Polydrug and Depressive Symptoms as Predictors.

    AIDS AND BEHAVIOR . : .

    [doi:10.1007/s10461-025-04695-x]

  • Pérez-Valero I, Mata DC, Espejo AC, Gallo M, de Morales AGG, Fanciulli C, Carbonero LM, Isbert SC, Gutiérrez CH, Asensi V, Juarez AR, Rivero A.

    Real-world effectiveness and safety of BIC/FTC/TAF in comparison with other regimens in people with HIV starting therapy with AIDS-defining conditions. Results from the CORIS Cohort: The ACTUAS II Study.

    CLINICAL INFECTIOUS DISEASES . : .

    [doi:10.1093/cid/ciaf162]

  • Rodríguez-Goncer I, Ruiz-Arabi E, Herrera S, Sabé N, Los-Arcos I, Silva JT, Pérez-Nadales E, Machuca I, Álvarez R, Valerio M, Castón JJ, Aguilera V, Bodro M, Cano Á, Cantón R, Carmona P, Carratalà J, Cordero E, Cruzado JM, Fariñas MC, Fernández-Ruiz M, Fondevila C, Fortún J, García-Cosío MD, Gutiérrez-Dalmau A, Iturbe D, Justo I, Len O, López-Medrano F, López Oliva MO, Martín-Dávila P, Martínez-Martínez L, Mazuecos A, Mirabet S, Muñoz P, Oliver A, Pérez-Sáez MJ, Rodríguez-Gómez J, San-Juan R, Sánchez-Céspedes J, Solé A, Vidal Verdú E, Villa J, Torre-Cisneros J, Aguado JM.

    Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.

    TRANSPLANTATION REVIEWS . 39(3): 100937-100937.

    [doi:10.1016/j.trre.2025.100937]

  • Maertens JA, Thompson GR 3rd, Spec A, Donovan FM, Hammond SP, Bruns AHW, Rahav G, Shoham S, Johnson R, Rijnders B, Schaenman J, Hoenigl M, Morrissey CO, Mehta SR, Heath CH, Koehler P, Paterson DL, Slavin MA, Fortún J, Nguyen MH, Patterson TF, Uspenskaya O, Van de Veerdonk FL, Verweij PE, Aoun M, Georgala A, Alexander BD, Chayakulkeeree M, Mehra V, Miceli MH, Sikka MK, Solé A, Walsh TJ, Aguado JM, Holland SM, Moussa M, Rautemaa-Richardson R, Bazaz R, Schwartz S, Walsh SR, Plate M, Yehudai-Ofir D, Brüggemann RJ, Cornely OA, Ostrosky-Zeichner L, Vazquez JA, White PL, Cornelissen K, Ross GG, Fitton L, Dane A, Zinzi D, Rex JH, Chen SC.

    Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study.

    LANCET INFECTIOUS DISEASES . : .

    [doi:10.1016/S1473-3099(25)00224-5]

  • Ron R, Díaz-García C, Sendagorta E, Cabello-Úbeda A, Moreno E, Crespillo-Andújar C, Feltes-Ochoa R, Carrillo-Acosta I, Navarro-Soler R, Esteban H, Górgolas M, Moreno S, Pérez-Molina JA, Serrano-Villar S.

    A Phase IV, open-label, single-arm, multicentric clinical trial for evaluation of Human Papillomavirus 9vHPV vaccine immunogenicity in Men Who Have Sex with Men living with HIV: GeSIDA Study 10017.

    CLINICAL INFECTIOUS DISEASES . : .

    [doi:10.1093/cid/ciaf435]

  • Fortún J, Suárez M.

    Survival and quality-of-life in Mucormycosis.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . : .

    [doi:10.1016/j.cmi.2025.07.034]

  • Pérez-Molina JA, Moreno E, Crespillo-Andújar C, Chamorro-Tojeiro S, Arsuaga M, Olavarrieta L, Martín O, Monge-Maillo B, Norman F, Lanza VF, Serrano-Villar S.

    Chagas disease induces gut microbial metabolic stress: Disruption of energy and nucleotide pathways and partial reversal by antiparasitic therapy (TRIPOBIOME-2 study).

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 67: 102881-102881.

    [doi:10.1016/j.tmaid.2025.102881]

  • Gayoso Cantero D, Corbacho Loarte MD, Monge Maillo B.

    Diagnostic delay in Strongyloides stercoralis infections.

    MEDICINA CLINICA . 165(5): 107123-107123.

    [doi:10.1016/j.medcli.2025.107123]

  • Huits R, Buonfrate D, O'Laughlin K, Hamer DH, Libman M.

    Measles importations by international travelers, GeoSentinel 2019-2025.

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 67: 102885-102885.

    [doi:10.1016/j.tmaid.2025.102885]